Aave
AAVE
Fundamental comparison between Aave and Nym
Not Financial Advice
This page is an informational analysis, not investment advice. The CryptoValue Score is an algorithmically generated rating from public data — it does not replace professional advice. Cryptocurrencies are highly volatile; total loss is possible. Read full risk disclaimer →
Aave
Nym
Detailed Comparison
| Metric | Aave | Nym |
|---|---|---|
| Price | $99.97 | $0.017935 |
| Market Cap | $1.54B | $15.05M |
| 24h Volume | 266.9M | 1.2M |
| Rank | #50 | #— |
| Circulating Supply | 15.4M | 839.3M |
| ATH | $661.69 | $5.76 |
Aave vs Nym — Analysis
Aave and Nym are two of the most prominent cryptocurrencies in the market. This comparison analyzes both coins based on their current price, market capitalization, trading volume, and — most importantly — their CryptoValue Value Score, which is calculated from 10 fundamental on-chain and market metrics.
Value Score Comparison
With a Value Score of 69.2, Aave is currently rated as "undervalued", while Nym scores 66.8 and is rated "undervalued". This means our algorithm considers Aave the fundamentally stronger investment.
Market Cap & Risk
Aave has a 102x larger market capitalization than Nym. A larger market cap typically means less volatility but also less growth potential. Nym may offer more upside but comes with higher risk.
Price Performance
Over the last 24 hours, Aave moved 3.50%, while Nym changed 3.90%. Looking at the 7-day window, Aave is at 4.40% and Nym at 7.30%.
Distance from All-Time High
Aave currently trades at 15% of its all-time high ($661.69), while Nym sits at 0% of its ATH ($5.76). Coins trading far below their ATH can represent either a buying opportunity or a warning sign — the Value Score helps distinguish between the two.
Conclusion
Based on our fundamental analysis, Aave (Score: 69.2) currently has a stronger investment case than Nym (Score: 66.8). However, the Value Score is a snapshot that changes daily. We recommend monitoring both coins regularly and conducting your own research before making any investment decisions.
